PaulDMillerMD
Nephrology • Lakewood, CORenal Metabolism
Distinguished Clinical Professor of Medicine, University of Colorado Health Sciences Center
Dr. Miller is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
6655 West Jewell Avenue
Suite 2
Lakewood, CO 80232Phone+1 303-284-2352Fax+1 303-284-2384
Education & Training
University of ColoradoFellowship, Nephrology, 1974 - 1976
University of RochesterChief Residency, Internal Medicine, 1973 - 1974- University of RochesterResidency, Internal Medicine, 1970 - 1973
George Washington University School of Medicine and Health SciencesClass of 1970
Certifications & Licensure
CO State Medical License 1974 - 2025
TX State Medical License 2023 - 2025
Publications & Presentations
PubMed
- 152 citationsEarly Responsiveness of Women with Osteoporosis to Teriparatide After Therapy with Alendronate or RisedronatePaul D. Miller, Pierre D. Delmas, Robert Lindsay, Nelson B. Watts, Marjorie M. Luckey
The Journal of Clinical Endocrinology and Metabolism. 2009-01-14 - 56 citationsOnce-monthly oral ibandronate compared with weekly oral alendronate in postmenopausal osteoporosis: results from the head-to-head MOTION study.Paul D. Miller, Sol Epstein, Farhad Sedarati, Jean-Yves Reginster
Current Medical Research and Opinion. 2008-01-01 - 17 citationsEffects of intravenous ibandronate injection on renal function in women with postmenopausal osteoporosis at high risk for renal disease--the DIVINE study.Paul D. Miller, Sergio Ragi-Eis, Carlos Mautalen, Francisco Ramirez, Iris Jonkanski
Bone. 2011-12-01
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
